The M&A market for physician groups has been booming this year, with 132 deals on the books through the end of April, according to search results in our Healthcare Deals Database. Strategic buyers, health systems and private equity firms are quickly expanding their regional and national platforms, capitalizing on the still-fragmented market. Enter U.S. Oral Surgery Management (USOSM), which just announced three deals in April, widening its footprint across the southern United States.
USOSM, a portfolio company of RiverGlade Capital and The Thurston Group, is a specialty management services company focused on oral and maxillofacial surgeons. The company was formed in 2017. On April 13, USOSM announced the addition of Atlantic Oral Surgery and Implant Center (1 physician), which provides a full scope of oral and maxillofacial surgery (OMS) services, including tooth extraction, dental implants, wisdom teeth removal, orthognathic surgery, bone grafting, and facial trauma and reconstructive surgery. This is USOSM’s first partnership in South Carolina.
On April 22, USOSM purchased Kingwood Oral Surgery based in Kingwood, Texas. Kingwood Oral Surgery is an oral and maxillofacial surgery practice serving the Kingwood area in Texas. The owner of the practice, Dr. Gary W. McDonald, was planning to retire before this deal but has agreed to stay on. The practice and staff will remain in the same location and plans to expand by adding another physician.
Then finally, on April 27, USOSM made ground in Mississippi with the addition of Oral and Maxillofacial Surgery Associates, an oral and maxillofacial surgery practice with two locations near Jackson. The practice offers a full scope of OMS services, such as tooth extraction, wisdom teeth removal, dental implants, TMJ disorder treatment, bone grafting, frenectomy, orthognathic surgery, tori reduction, and more.
In 2019, USOSM announced seven transactions across six states, but in 2020, when the Covid-19 pandemic hit, the PE-backed physician group only announced one deal. With plenty of deal activity already on the books in 2021, we expect to see USOSM keep up the momentum throughout the year.